Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows used in operating activities:
Net loss	$ (93)	$ (8,743)
Adjustments to reconcile net loss to net cash used in operating activities (see Schedule A)	(2,916)	12,447
Net cash provided by (used in) operating activities – continuing operations	(3,009)	3,704
Net cash used in operating activities – discontinued operations	(872)	(2,747)
Net cash provided by (used in) operating activities	(3,881)	957
Cash flows provided by (used in) investing activities:
Acquisitions of property and equipment	(33)	(156)
Proceeds from the sale of interests in DSIT, net of transaction costs and cash divested	3,947
Escrow deposits	(579)	(100)
Release of escrow deposits	100
Restricted deposits	(75)	(7,139)
Release of restricted deposits	868	1,700
Amounts funded for severance assets	(69)	(274)
Net cash provided by (used in) investing activities – continuing operations	4,159	(5,969)
Net cash provided by investing activities – discontinued operations	900	725
Net cash provided by (used in) investing activities	5,059	(5,244)
Cash flows provided by (used in) financing activities:
Short-term credit, net	827	382
Proceeds from the exercise of DSIT options	391
Repayment of Leap Tide loan	(2,000)
Proceeds from Leap Tide transaction		2,000
Proceeds from director loans	375
Repayments of director loans	(275)
Repayments of long-term debt	(43)	(96)
Net cash provided by (used in) financing activities – continuing operations	(725)	2,286
Net cash used in financing activities – discontinued operations	(138)	(2,180)
Net cash provided by (used in) financing activities	(863)	106
Effect of exchange rate changes on cash and cash equivalents – continuing operations	(5)
Effect of exchange rate changes on cash and cash equivalents – discontinued operations	18	(160)
Net increase (decrease) in cash and cash equivalents	328	(4,341)
Cash and cash equivalents at the beginning of the year – discontinued operations	48	192
Cash and cash equivalents at the beginning of the year – continuing operations	124	4,681
Cash and cash equivalents at the end of the period – discontinued operations	396	54
Cash and cash equivalents at the end of the period – continuing operations	104	478
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Loss from discontinued operations	423	4,250
Depreciation and amortization	126	228
Accretion of Leap Tide discount	100	66
Common stock issued for Leap Tide interest accrued	281
Conversion to common stock of interest due to director	15
Gain on sale of interests in DSIT, net of income taxes and transaction costs	(3,543)
Share of income in DSIT	(63)
Increase in accrued severance	67	301
Stock-based compensation	243	523
Deconsolidation of USSI		401
Deferred taxes	18	42
Other	35	(42)
Change in operating assets and liabilities:
Decrease (increase) in accounts receivable, unbilled revenue, other current and other assets	(148)	798
Decrease (increase) in inventory	(30)	14
Increase (decrease) in deferred revenue	(1,055)	4,316
Increase in accounts payable, accrued payroll, payroll taxes and social benefits, other current liabilities and other liabilities	615	1,550
Adjustments to reconcile net loss to net cash provided by (used in) operating activities, total	(2,916)	12,447
Non-cash investing and financing activities:
Adjustment of paid-in-capital and non-controlling interest from the deconsolidation of DSIT	242
Conversion of director loan to common stock	100
Accrual of preferred dividends to outside investor in OmniMetrix	75
Investment in DSIT from deconsolidation	$ 5,391
Liability/discount for put on Initial Shares in Leap Tide transaction		340
Liability for put on Vested Share Rights in Leap Tide transaction		111
Value of Initial shares (discount) in Leap Tide transaction		162
Adjustment of paid-in-capital and non-controlling interest from the deconsolidation of USSI		$ 541